FREELINE THERAPEUTICS HOLDIN (FRLN) Stock Analyst Ratings
NASDAQ:FRLN - Nasdaq - US35655L2060 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to FRLN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.42. This target is 29.86% above the current price.
FRLN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FRLN.
In the previous month the buy percentage consensus was at a similar level.
FRLN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-28 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-10-18 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-08-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-16 | Stifel | Maintains | Hold -> Hold |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-01 | Stifel | Reiterate | Hold -> Hold |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-05 | Stifel | Downgrade | Buy -> Hold |
| 2023-04-05 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-22 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-11 | BTIG | Maintains | Buy |
| 2022-02-01 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-01-07 | Redburn Partners | Upgrade | Neutral -> Buy |
| 2021-11-29 | BTIG | Initiate | Buy |
| 2021-08-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-17 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-05-19 | HC Wainwright & Co. | Initiate | Buy |
| 2021-05-06 | Guggenheim | Initiate | Buy |
| 2021-04-06 | Morgan Stanley | Maintains | Overweight |
| 2021-03-23 | Mizuho | Initiate | Buy |
| 2021-03-02 | Stifel | Initiate | Buy |